Corpus 1,273 assessed · 1,174 scored · 643 reproduced ≥75 · 169 flagged ·∅ 74.1/100

Publications 3 Datasets 392.5k Experiments 4.7k

Explore

Filters: Front Oncol ✕ low ✕ 1 ✕ clear all

3 matching publication(s)

Publication	Journal	Year	Score	Verdict
Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients. PMID 35425715	Front Oncol	2022	53	L1 53/100
Bacillus Calmette-Guérin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer. ⚑ PMID 35311085	Front Oncol	2022	30	L1 30/100 ⚑
Inference of Subpathway Activity Profiles Reveals Metabolism Abnormal Subpathway Regions in Glioblastoma Multiforme. PMID 33072547	Front Oncol	2020	89	L1 89/100

Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients.

PMID 35425715 · Front Oncol · 2022

L1 53/100

Bacillus Calmette-Guérin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer.⚑

PMID 35311085 · Front Oncol · 2022

L1 30/100 ⚑

Inference of Subpathway Activity Profiles Reveals Metabolism Abnormal Subpathway Regions in Glioblastoma Multiforme.

PMID 33072547 · Front Oncol · 2020

L1 89/100